The Effect of Preoperative Antiplatelet/Anticoagulant Prophylaxis on Postoperative Blood Loss in Cardiac Surgery
- 1 January 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 98 (1) , 4-10
- https://doi.org/10.1213/01.ane.0000093227.95876.f4
Abstract
In this study we sought to determine whether preoperative treatment with antiplatelet and/or anticoagulant drugs influences postoperative blood loss after coronary artery bypass graft surgery. Although prophylactic treatment to prevent ischemic events preoperatively is often necessary, the treatmentKeywords
This publication has 19 references indexed in Scilit:
- Pharmacologic preservation of the hemostatic system during cardiac surgeryThe Annals of Thoracic Surgery, 2001
- Antiplatelet Agents in Stroke PreventionCerebrovascular Diseases, 2000
- Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapyJournal of the American College of Cardiology, 2000
- Platelet inhibitors and cardiac surgeryThe Annals of Thoracic Surgery, 2000
- Platelet inhibitors and bleeding in cardiac surgical patientsThe Annals of Thoracic Surgery, 2000
- Management approaches to platelet-related microvascular bleeding in cardiothoracic surgeryThe Annals of Thoracic Surgery, 2000
- Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitro.Journal of Thrombosis and Thrombolysis, 2000
- Preoperative Use of Enoxaparin and Tirofiban: Possible Association with Increased Bleeding PostbypassAnesthesiology, 1999
- Abciximab and Excessive Bleeding in Patients Undergoing Emergency Cardiac OperationsThe Annals of Thoracic Surgery, 1998
- Ticlopidine as a Hemorrhagic Risk Factor in Coronary SurgeryDrug Intelligence & Clinical Pharmacy, 1985